NeuroOne Medical Technolo... (NMTC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1 |
Market Cap | 31.43M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.46 |
PE Ratio (ttm) | -2.21 |
Forward PE | n/a |
Analyst | Buy |
Ask | 1.06 |
Volume | 450,196 |
Avg. Volume (20D) | 201,651 |
Open | 1.03 |
Previous Close | 1.05 |
Day's Range | 0.94 - 1.09 |
52-Week Range | 0.55 - 1.59 |
Beta | undefined |
About NMTC
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to fa...
Analyst Forecast
According to 1 analyst ratings, the average rating for NMTC stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Why Price Moved
News
3 months ago · prismmediawire.com
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity ConferenceEDEN PRAIRIE, Minn.